{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:01:55Z","timestamp":1773270115268,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12040208"],"award-info":[{"award-number":["XDA12040208"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"R&D Program of Shanghai Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["14431905500"],"award-info":[{"award-number":["14431905500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejmech.2017.12.099","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T03:01:12Z","timestamp":1515034872000},"page":"74-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect"],"prefix":"10.1016","volume":"145","author":[{"given":"Mingshuo","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feipu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangrui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junchi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingshan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hualiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.12.099_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","article-title":"Size of burden of schizophrenia and psychotic disorders","volume":"15","author":"Rossler","year":"2005","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2017.12.099_bib2","series-title":"Schizophrenia","author":"Weinberger","year":"2011"},{"key":"10.1016\/j.ejmech.2017.12.099_bib3","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2013"},{"key":"10.1016\/j.ejmech.2017.12.099_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ppc.12111","article-title":"Clinical management of antipsychotic-induced hyperprolactinemia","volume":"52","author":"Wong-Anuchit","year":"2016","journal-title":"Perspect. Psychiatr. Care"},{"key":"10.1016\/j.ejmech.2017.12.099_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pscychresns.2011.02.004","article-title":"The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study","volume":"201","author":"Corripio","year":"2012","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.ejmech.2017.12.099_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1073858415602850","article-title":"Doping the mind: dopaminergic modulation of prefrontal cortical cognition","volume":"22","author":"Ranganath","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejmech.2017.12.099_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2017.12.099_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12374","article-title":"Second-generation antipsychotic effect on cognition in patients with schizophrenia\u2014a meta-analysis of randomized clinical trials","volume":"131","author":"Nielsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejmech.2017.12.099_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2017.12.099_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2017.10.025","article-title":"Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT1\/MT2) and serotoninergic (5-HT2C) dual ligands","volume":"141","author":"Duroux","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors : their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.12.099_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2017.12.099_bib13","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.2174\/1381612821666150605105215","article-title":"Serotonin 5-HT1A receptors and antipsychotics - an update in light of new concepts and drugs","volume":"21","author":"McCreary","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2017.12.099_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.12.099_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","article-title":"The Serotonin-1A receptor in anxiety disorders","volume":"66","author":"Akimova","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejmech.2017.12.099_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/npp.2013.185","article-title":"Developmental effects of serotonin 1A autoreceptors on anxiety and social behavior","volume":"39","author":"Donaldson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2017.12.099_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT1A receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2017.12.099_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/nn.4116","article-title":"5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response","volume":"18","author":"Samuels","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2017.12.099_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.pnpbp.2010.04.005","article-title":"Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders","volume":"34","author":"Shimizu","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.12.099_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1017\/S1461145713000151","article-title":"Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis","volume":"16","author":"Kishi","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2017.12.099_bib21","first-page":"357","article-title":"Facilitative effect of serotonin1A receptor agonists on cognition in patients with schizophrenia","volume":"20","author":"Sumiyoshi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1017\/S1092852913000771","article-title":"Pharmacotherapy of cognitive deficits in schizophrenia","volume":"19","author":"Opler","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ejmech.2017.12.099_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2010.02.001","article-title":"The effectiveness of multi-target agents in schizophrenia and mood disorders: relevance of receptor signature to clinical action","volume":"126","author":"Wong","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2017.12.099_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejmech.2016.09.050","article-title":"Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists","volume":"125","author":"Franchini","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmech.2017.05.047","article-title":"Synthesis of a new series of aryl\/heteroarylpiperazinyl derivatives of 8-acetyl-7-hydroxy-4-methylcoumarin with low nanomolar 5-HT1A affinities","volume":"137","author":"Ostrowska","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib26","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1134\/S1070428007110097","article-title":"Stereochemistry of dihydroxylation of N-arylbicyclo[2.2.1]-hept-5-ene-endo- and -exo-2,3-dicarboximides","volume":"43","author":"Bagmanov","year":"2007","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib27","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.bmcl.2011.01.059","article-title":"Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder","volume":"21","author":"Johnson","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.099_bib28","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/jm400408r","article-title":"Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics","volume":"56","author":"Chen","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib29","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1016\/j.bmc.2015.04.026","article-title":"Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent","volume":"23","author":"Czopek","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/0929867023371030","article-title":"Arylpiperazine derivatives acting at 5-HT1A receptors","volume":"9","author":"Lopez-Rodriguez","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.099_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2017.12.099_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","article-title":"Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system","volume":"135","author":"Leung","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2017.12.099_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2017.12.099_bib34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40263-013-0115-5","article-title":"Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor","volume":"27","author":"Weston-Green","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2017.12.099_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A\u00a0mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2017.12.099_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coph.2004.08.008","article-title":"PCP: from pharmacology to modelling schizophrenia","volume":"5","author":"Morris","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.12.099_bib37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1017\/S1461145713000606","article-title":"Preclinical models of antipsychotic drug action","volume":"16","author":"Moreno","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2017.12.099_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/jpet.113.207209","article-title":"Nonhuman primates: translational models for predicting antipsychotic-induced movement disorders","volume":"347","author":"Porsolt","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417311303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417311303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T18:53:04Z","timestamp":1733770384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417311303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"alternative-id":["S0223523417311303"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.099","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}